These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2461022

  • 1. HLA class II restriction specificity for nickel-reactive T lymphocytes.
    Emtestam L, Marcusson JA, Möller E.
    Acta Derm Venereol; 1988; 68(5):395-401. PubMed ID: 2461022
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T, Tsukamoto K, Hirayama K, Nishimura Y, Takenouchi T, Aizawa M, Sasazuki T.
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [Abstract] [Full Text] [Related]

  • 8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D, Radka SF, Igarashi M, Kreider BL, Ferrone S.
    J Immunol; 1986 Jul 15; 137(2):400-7. PubMed ID: 2941479
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D, Marković-Lipkovski J, Hadzi-Djokić J, Müller GA, Müller CA.
    Neoplasma; 1999 Jul 15; 46(3):173-8. PubMed ID: 10613593
    [Abstract] [Full Text] [Related]

  • 10. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
    Robbins PA, Maino VC, Warner NL, Brodsky FM.
    J Immunol; 1988 Aug 15; 141(4):1281-7. PubMed ID: 3135327
    [Abstract] [Full Text] [Related]

  • 11. HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.
    Noreen HJ, Davidson ML, McCullough J, Bach FH, Segall M.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 3):2968-70. PubMed ID: 2468247
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD, Lipsky PE.
    J Immunol; 1985 Dec 15; 135(6):3750-62. PubMed ID: 3934267
    [Abstract] [Full Text] [Related]

  • 20. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M, Yano A.
    J Immunol; 1985 Dec 15; 135(6):3887-96. PubMed ID: 2999233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.